Segar v. Ashcroft

District Court, District of Columbia·Decided March 28, 2025·No. Civil Action No. 1977-0081·Published

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

HENRY W. SEGAR, et al., Plaintiffs,

v.

Civ. Action No. 77-0081 (EGS)

PAMELA J. BONDI, U.S. Attorney General, et al.,

Defendants.1

MEMORANDUM OPINION

“Title VII of the Civil Rights Act of 1964 proclaims one of this nation’s most fundamental, if yet unrealized, principles: a person shall not be denied full equality of employment opportunity on account of [their] race . . . .” Segar v. Smith, 738 F.2d 1249, 1258 (D.C. Cir. 1984). For nearly fifty years, African American Special Agents (“Plaintiffs”) at the Drug Enforcement Agency (“DEA” or “Agency”), have fought for their employer, their country, to live up to this obligation.

1 According to Plaintiffs’ Motion for Preliminary Approval, “[w]hile the United States does not waive this argument [that the DEA Administrator is not a proper defendant], it agrees for purposes of filings concerning this settlement to use of the plural form “defendants” for ease of reading.” Mot. for Prelim. Approval, ECF No. 502 at 2. Pursuant to Rule 25(d) of the Federal Rules of Civil Procedure, the current Attorney General and DEA Administrator are substituted for the prior Attorney General and DEA Administrator. See Fed. R. Civ. P. 25(d).

Among these Plaintiffs are a group of African American Special Agents (“Damages Class”) who were denied promotions to GS-14 or GS-15 positions between 1993 and 2022, despite making the Best Qualified List (“BQ List”), under promotion procedures that were found to violate the law and this Court’s orders. The Court agrees that “[d]amages cannot entirely remedy that harm, as money cannot give Black Special Agents the opportunities to lead and otherwise serve their country at the highest levels— opportunities that those agents earned through years of hard work and putting their lives on the line.” Pls.’ Mot. for Individual Relief, ECF No. 486 at 1. But the Proposed Partial Settlement Agreement (“Proposed Settlement”) now before the Court will finally provide some amount of compensation to these public servants whose lives and careers were mired in decades of injustice. On March 24, 2025, this Court held a Fairness Hearing (“Fairness Hearing”) during which it issued a bench ruling approving the Proposed Settlement. See Mot. for Final Approval, ECF No. 512.2 This Memorandum Opinion memorializes that ruling.

2 When citing electronic filings throughout this Opinion, the Court cites to the ECF header page number, not the page number of the filed document.

I. Background A. Underlying Litigation The DEA was established as part of the Justice Department in 1973 to “enforce[] this nation’s federal criminal laws concerning the illegal sale, distribution, and use of drugs.” See Segar, 738 F.2d at 1258. The “bulk of the DEA’s criminal investigative work” is done by “Special Agents.” Id. At the time this case commenced, the DEA “employ[ed] about 2,000” Special Agents, “and as of 1978, [only] seven percent were [B]lack.” Id.

In 1977, Plaintiffs filed a Title VII action alleging that the DEA discriminated against them in its employment practices. Id. at 1258–60 (Plaintiffs “alleged discrimination in recruitment, hiring, initial grade assignments, salary, work assignments, evaluations, discipline, and promotions”). The Court certified a class of all African Americans “who had then served or . . . had been discharged as [S]pecial [A]gents at DEA, and who had applied for positions or would in the future apply.” Id. at 1260–61. After a two-week trial in 1979, the Court agreed that the DEA had discriminated against Plaintiffs with respect to their salary, grade at entry, work assignments, supervisory evaluations, discipline, and promotions. See Segar v. Civiletti, 508 F. Supp. 690, 712–15 (D.D.C. 1981), aff’d in part, rev’d in part, Segar v. Smith, 738 F.2d at 1296

(“affirm[ing] the District Court’s liability determination in its entirety”). The United States Court of Appeals for the District of Columbia Circuit (“D.C. Circuit”) affirmed the Court’s liability determination in full, but vacated some of the Court’s remedial measures and remanded the case for further proceedings. See Segar, 738 F.2d at 1296.

After the 1981 trial, the Court “directed the parties to submit proposals for further relief.” Segar v. Smith, Civ. No. 77-81, 1982 WL 214, at *1 (D.D.C. Feb. 17, 1982). It adopted Plaintiffs’ proposal and ordered, inter alia, that the DEA “shall not discriminate against any [B]lack agent because of his race, color or national origin, with respect to . . . promotions” and that it shall “develop and implement new, nondiscriminatory employment systems with respect to . . . promotions.” Id., at *4. Since then, the parties have engaged in litigation to effectuate the Court’s order enjoining the DEA from engaging in discriminatory practices. See Segar v. Barr, No. 77-cv-81, 2019 WL 2605591, at *1 (D.D.C. June 25, 2019).

A comprehensive history of this litigation exists in the record and in the Court’s prior opinions; this Memorandum Opinion focuses on the events that led to the Proposed Settlement. Fulsome review of the record makes clear, however, that an extraordinary amount of effort, time, and resources went

into ensuring that the DEA complies with its obligations. As the Court noted at the Fairness Hearing, all the Damages Class members, especially members of the EEOMC, Class Counsel, Working Group, and Defendants deserve recognition for negotiating a settlement to account for decades of wrongdoing. This case has spanned multiple judges, including Judge Aubrey E. Robinson, who presided over this case from 1977 until he passed away on February 27, 2000, shortly before the case was reassigned to this Court on March 29, 2000; Magistrate Judge John M. Facciola, who presided over numerous disputes and settlement negotiations throughout the decades; and Magistrate Judge Zia M. Faruqui, who assisted in settlement negotiations shortly before the parties reached their Proposed Settlement here. These judges, similarly to the parties and all those affected by the DEA’s actions, deserve recognition for their roles in facilitating the pursuit of justice and accountability.

B. Discriminatory Promotion Procedures In response to the Court’s 1982 order for the DEA to implement nondiscriminatory procedures, including for promotions, the DEA implemented two sets of procedures that ended up themselves being discriminatory. First, the DEA implemented the Special Agent Promotion Process (“SAPP”) in 1992. See Op., ECF No. 35. Under the SAPP, agents who scored

high were placed on the BQ List for a position. Id. at 2. Agents on the BQ List were considered “equally qualified for promotion to the vacant position.” Id. Simultaneously, the Special Agent in Charge (“SAC”) for the division with the vacancy could “submit a list of his recommendations in order of preference.” Id. The DEA’s Career Board would then select an agent for the promotion. Id.

In 1997, Plaintiffs filed a motion for compliance order in which they argued that the SAPP continued to discriminate against them in violation of law and court order. Id. In 1999, the Court granted Plaintiff’s motion in part and held that “the use of SAC short list recommendations for promotions to Grades 14 and 15 violate[d] this Court’s remedial orders and Title VII of the Civil Rights Act of 1964.” Id. at 22–23; see also Order, ECF No. 36. The Court “enjoin[ed] the use of SAC recommendations until such time as their use can be validated as consistent with the agency’s obligations under law.” Op., ECF No. 35 at 22. It also “ask[ed] the parties to brief the question of fashioning individual relief.” Id.

Second, and in response to the Court’s 1999 order, the parties negotiated “Interim Procedures” for GS-14 and GS-15 promotions, which the Court approved. See Mot. for Prelim. Approval, ECF No. 502 at 3. The parties could not negotiate a

Free access — add to your briefcase to read the full text and ask questions with AI

Segar v. Ashcroft, (D.D.C. 2025).

Segar v. Ashcroft (Segar v. Ashcroft) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Amchem Products, Inc. v. Windsor
521 U.S. 591 (Supreme Court, 1997)
Thomas, Walter J. v. Albright, Madeleine
139 F.3d 227 (D.C. Circuit, 1998)
In Re Vitamins Antitrust Class Actions
215 F.3d 26 (D.C. Circuit, 2000)
Segar v. Civiletti
508 F. Supp. 690 (District of Columbia, 1981)
Trombley v. National City Bank
826 F. Supp. 2d 179 (District of Columbia, 2011)
Little v. Washington Metropolitan Area Transit Authority
249 F. Supp. 3d 394 (District of Columbia, 2017)
J.D. v. Alex Azar, II
925 F.3d 1291 (D.C. Circuit, 2019)
Taylor v. District of Columbia Water & Sewer Authority
241 F.R.D. 33 (District of Columbia, 2007)
Thomas v. Christopher
169 F.R.D. 224 (District of Columbia, 1996)